Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IRHYTHM TECHNOLOGIES, INC.

(IRTC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IRhythm Technologies Shares Surge Following CMS 2022 Medicare Physician Fee Schedule Final Rule

11/03/2021 | 01:55pm EST


ę MT Newswires 2021
All news about IRHYTHM TECHNOLOGIES, INC.
01/19NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
01/18Morgan Stanley Lifts IRhythm Technologies to Overweight From Equalweight, Price Target ..
MT
01/14Canaccord Genuity Adjusts iRhythm Technologies' Price Target to $160 from $125, Keeps B..
MT
01/14Citigroup Adjusts iRhythm Technologies' PT to $165 from $120, Keeps Buy Rating
MT
01/13Truist Securities Adjusts IRhythm Technologies' Price Target to $185 From $130, Reitera..
MT
01/13NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
01/12BTIG Upgrades IRhythm Technologies to Buy From Neutral; Price Target is $170
MT
01/12TONY XU : All Eyes on -2-
DJ
01/11IRhythm Technologies Shares up Tuesday After Oppenheimer's Upgrade
MT
01/11Oppenheimer Upgrades IRhythm Technologies to Outperform From Perform; Price Target is $..
MT
More news
Analyst Recommendations on IRHYTHM TECHNOLOGIES, INC.
More recommendations
Financials (USD)
Sales 2021 319 M - -
Net income 2021 -105 M - -
Net cash 2021 70,9 M - -
P/E ratio 2021 -34,0x
Yield 2021 -
Capitalization 3 587 M 3 587 M -
EV / Sales 2021 11,0x
EV / Sales 2022 8,87x
Nbr of Employees 1 157
Free-Float 98,3%
Chart IRHYTHM TECHNOLOGIES, INC.
Duration : Period :
iRhythm Technologies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IRHYTHM TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 121,89 $
Average target price 156,25 $
Spread / Average Target 28,2%
EPS Revisions
Managers and Directors
Quentin S. Blackford President, Chief Executive Officer & Director
Douglas J. Devine Chief Operating & Financial Officer
Abhijit Y. Talwalkar Chairman
Judith Lenane Chief Clinical Officer & Executive VP-Products
Mark J. Day Executive Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
IRHYTHM TECHNOLOGIES, INC.3.57%3 587
THERMO FISHER SCIENTIFIC-14.91%223 721
DANAHER CORPORATION-17.57%193 793
INTUITIVE SURGICAL, INC.-26.48%94 361
SIEMENS HEALTHINEERS AG-12.03%73 251
EDWARDS LIFESCIENCES CORPORATION-15.48%68 358